A pharmaceutical company has tested a new, experimental drug for Parkinson's disease. Compared with drugs currently prescribed, the new drug decreases symptoms such as tremors, limb stiffness, impaired balance and slow movement by 30 per cent. However, compared with the existing drugs, the mortality rate of patients taking the new drug (those dying because of serious side effects) has increased by 200 per cent. The mortality rate of the existing drugs is 1 in 350,000 patients Would you decide to bring this new drug to the market? Justify your